Patients who are prescribed isotretinoin must enroll in the iPledge program and comply with its requirements. This includes undergoing regular pregnancy tests and using two forms of contraception. Prescribers and pharmacists must also register and adhere to specific protocols, such as verifying negative pregnancy tests before dispensing the medication.
